2026-06-03T04:48:46Zhttps://riuma.uma.es/rest/oai/request

oai:riuma.uma.es:10630/412682026-02-03T11:03:48Zcom_10630_2254col_10630_37953

ECMO in severe hypoxemia post liver transplant for hepatopulmonary syndrome Barrueco Francioni, Jesus Emilio Martínez González, María Carmen Martínez Carmona, Juan Francisco Benítez-Moreno, Palma Aragón González, César Herrera-Gutiérrez, Manuel Enrique Hígado - Trasplante Cuidados intensivos https://openpolicyfinder.jisc.ac.uk/id/publication/11484?from=single_hit Hepatopulmonary syndrome (HPS) poses a significant challenge in liver transplant patients, affecting between 10% and 30% of candidates. Historically, HPS was considered a contraindication for liver transplantation due to its association with high mortality rates. However, recent studies have shown improvements in pulmonary function post-transplant, leading to the inclusion of these patients as candidates. Despite this progress, approximately one-fifth of liver transplant recipients develop severe postoperative hypoxia, further complicating their clinical course and contributing to increased mortality. The management of post-transplant HPS involves various strategies, including extracorporeal membrane oxygenation (ECMO), although its use remains infrequently reported. Theoretical models suggest that oxygenation typically improves within 10 days post-transplant, while resolution of HPS may take 6-12 months, making ECMO an attractive possibility as a bridge to recovery in this population. We present a case were ECMO was used in this context. 2025-12-19T11:04:49Z 2025-12-19T11:04:49Z 2024 journal article Barrueco-Francioni JE, Martínez-González MC, Martínez-Carmona JF, Benítez-Moreno MP, Aragón-González C, Herrera-Gutiérrez ME. ECMO in severe hypoxemia post liver transplant for hepatopulmonary syndrome. Int J Artif Organs. 2024 Nov;47(11):858-861. doi: 10.1177/03913988241274252. Epub 2024 Sep 2. PMID: 39221571. https://hdl.handle.net/10630/41268 10.1177/03913988241274252 eng open access Sage